In this book leading experts in cancer immunotherapy join forces to provide a comprehensive
guide that sets out the main principles of oncoimmunology and examines the latest advances and
their implications for clinical practice focusing in particular on drugs with FDA EMA
approvals and breakthrough status. The aim is to deliver a landmark educational tool that will
serve as the definitive reference for MD and PhD students while also meeting the needs of
established researchers and healthcare professionals. Immunotherapy-based approaches are now
inducing long-lasting clinical responses across multiple histological types of neoplasia in
previously difficult-to-treat metastatic cancers. The future challenges for oncologists are to
understand and exploit the cellular and molecular components of complex immune networks to
optimize combinatorial regimens to avoid immune-related side effects and to plan
immunomonitoring studies for biomarker discovery. The editors hope that this book will guide
future and established health professionals toward the effective application of cancer
immunology and immunotherapy and contribute significantly to further progress in the field.
